A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis
A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis
复制标题
DOI：
10.1002/art.23501
复制
发表时间：
2008-06-01
影响因子：
--
通讯作者：
Furst, Daniel E.
中科院分区：
文献类型：
--
作者：
Postlethwaite, Arnold E.;Wong, Weng Kee;Furst, Daniel E.
客观的。调查口服 I 型牛胶原蛋白 (CI) 治疗弥漫性皮肤系统性硬化症（dc-SSc；硬皮病）患者的安全性和有效性
Objective. To investigate the safety and efficacy of oral bovine type I collagen (CI) treatment in patients who have had diffuse cutaneous systemic sclerosis (dc-SSc; scleroderma) for